Stifel lowered the firm’s price target on WM (WM) to $236 from $252 and keeps a Buy rating on the shares. The firm lowering its target to reflect modestly lowered estimates and an increased risk premium due to more concerns around the Stericycle acquisition, but expects “very healthy” free cash flow in 2026 due largely to a step down of investment spending and increased profits generated from those investments, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WM: